Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials

202273 citationsReviewgreen Open Access

Authors

Hong Xiao · Fred Hutch Cancer Center

Riha Vaidya · Fred Hutch Cancer Center

Fang Liu · Chinese Center For Disease Control and Prevention

Ximing Chang · Imperial College London

Xiaoqian Xia · London School of Hygiene & Tropical Medicine

Joseph M. Unger · Fred Hutch Cancer Center

Abstract

In this systematic review and meta-analysis, aggregate differences in representation for several demographic groups in COVID-19 prevention and treatment trials in the US were found. Strategies to better ensure diverse representation in COVID-19 studies are needed, especially for prevention trials.

Topics & Keywords

Sex and Gender in Healthcare COVID-19 and healthcare impacts Ethics in Clinical Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Internal Medicine

Volume 183, Issue 1, pp. 50-50

DOI: 10.1001/jamainternmed.2022.5600

Field-Weighted Citation Impact: 13.57